Past reportsShow past reportsHide past reports
- Sep 23, 202647LiveOverall +2 · Mobile web +6 · CTA +5Viewing
- Sep 3, 202645First tracked report — strongest Information hierarchy 58, weakest CTA 25View →
Your landing page’s weakest score is CTA.
How Uncommon Therapeutics ranks
- 1.
Acadia Pharmaceuticals65
- 2.
Ultragenyx61
- 3.
Neurogene52
- 4.
Taysha Gene Therapies48
- 5.
Uncommon Therapeutics47
47Growth scoreupdated
category scores
category scoresShowHide
Score over time
CTA
30PoorCopy, size, verb, cost-feel — does the primary CTA earn the click?
Problems
- no CTA anywhere above the fold
- underlined text mimics link, no action
- only interactive element is video pause
- mobile fold has zero tappable actions
Trust
42PoorProof that the product is real, competent, and safe to try.
| Trust read | |
|---|---|
| Uncommon Therapeutics | "First indication: Rett Syndrome" line naming a specific disease program |
| No visible trust signal identified. | |
| No visible trust signal identified. | |
| Nav links to "Investors," "Pipeline," and "Healthcare Professionals" signaling an established public pharma company | |
| No visible trust signal identified. |
Mobile web
48PoorThe phone experience as a first-class citizen.
123- Eight-line hero headline — Desktop headline scales down poorly, wrapping into eight cramped lines with no CTA below it.
- Strikethrough and underline styling — The struck 'rare' plus underlined 'uncommon diseases' adds mid-sentence visual noise that slows reading.
- Bare wordmark header — No menu icon or link accompanies the wordmark, leaving mobile visitors no visible navigation path.
Information hierarchy
58FairDoes the design help or inhibit what the page is trying to say?
123- Struck-through 'rare' word — The strikethrough-and-underline wordplay makes the headline's final clause harder to parse at a glance.
- Video pause control — The only interactive element in the fold is a pause toggle, giving it more actionability than the message itself.
- Wordmark-only header — The header offers no nav or anchor, so visitors have zero orientation about what else exists on the page.
Value props
58FairTitle, subtitle, hero — do they sell the product's true value?
Uncommon Therapeutics’s headline undersells
Using the latest technologies to efficiently build drugs that target the underlying cause of rare uncommon diseases
Welcome to the unCommon Era (0 uCE).
Working
- Names root-cause outcome, not symptoms
- 'rare→uncommon' strikethrough is memorable
- Clear mission for patients and investors
Could improve
- 'Latest technologies' is generic filler
- No program named in the fold
- Subhead is wordplay, adds no specifics